137 related articles for article (PubMed ID: 12608943)
21. Association of BsmI vitamin-D receptor gene polymorphism with combined bone mass in spine and proximal femur in Icelandic women.
Sigurdsson G; Magnusdottir DN; Kristinsson JO; Kristjansson K; Olafsson I
J Intern Med; 1997 Jun; 241(6):501-5. PubMed ID: 10497626
[TBL] [Abstract][Full Text] [Related]
22. Association between vitamin D receptor BsmI polymorphism and bone mineral density in pediatric patients: A meta-analysis and systematic review of observational studies.
Bao L; Chen M; Lei Y; Zhou Z; Shen H; Le F
Medicine (Baltimore); 2017 Apr; 96(17):e6718. PubMed ID: 28445285
[TBL] [Abstract][Full Text] [Related]
23. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis.
Sarioglu M; Tuzun C; Unlu Z; Tikiz C; Taneli F; Uyanik BS
Rheumatol Int; 2006 Jan; 26(3):195-200. PubMed ID: 15580349
[TBL] [Abstract][Full Text] [Related]
25. Associations of polymorphisms in the vitamin D receptor gene (BsmI and FokI) with bone mineral density in postmenopausal women in Malta.
Vidal C; Grima C; Brincat M; Megally N; Xuereb-Anastasi A
Osteoporos Int; 2003 Nov; 14(11):923-8. PubMed ID: 14557853
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D receptor gene BsmI-polymorphism in Finnish premenopausal and postmenopausal women: its association with bone mineral density, markers of bone turnover, and intestinal calcium absorption, with adjustment for lifestyle factors.
Laaksonen M; Kärkkäinen M; Outila T; Vanninen T; Ray C; Lamberg-Allardt C
J Bone Miner Metab; 2002; 20(6):383-90. PubMed ID: 12434167
[TBL] [Abstract][Full Text] [Related]
27. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
[TBL] [Abstract][Full Text] [Related]
28. Polymorphism of the vitamin D receptor gene and corticosteroid-related osteoporosis.
Ho YV; Briganti EM; Duan Y; Buchanan R; Hall S; Seeman E
Osteoporos Int; 1999; 9(2):134-8. PubMed ID: 10367040
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral density, carotid artery intimal medial thickness, and the vitamin D receptor BsmI polymorphism in Mexican American women.
Kammerer CM; Dualan AA; Samollow PB; Périssé AR; Bauer RL; MacCluer JW; O'Leary DH; Mitchell BD
Calcif Tissue Int; 2004 Oct; 75(4):292-8. PubMed ID: 15549643
[TBL] [Abstract][Full Text] [Related]
30. Lack of Influence of Vitamin D Receptor BsmI (rs1544410) Polymorphism on the Rate of Bone Loss in a Cohort of Postmenopausal Spanish Women Affected by Osteoporosis and Followed for Five Years.
Pedrera-Canal M; Moran JM; Vera V; Roncero-Martin R; Lavado-Garcia JM; Aliaga I; Pedrera-Zamorano JD
PLoS One; 2015; 10(9):e0138606. PubMed ID: 26393357
[TBL] [Abstract][Full Text] [Related]
31. No major effect of estrogen receptor beta gene RsaI polymorphism on bone mineral density and response to alendronate therapy in postmenopausal osteoporosis.
Arko B; Prezelj J; Komel R; Kocijancic A; Marc J
J Steroid Biochem Mol Biol; 2002 Jun; 81(2):147-52. PubMed ID: 12137804
[TBL] [Abstract][Full Text] [Related]
32. Association of vitamin D receptor gene polymorphism (TaqI and Apa1) with bone mineral density in North Indian postmenopausal women.
Ahmad I; Jafar T; Mahdi F; Ameta K; Arshad M; Das SK; Waliullah S; Rizvi I; Mahdi AA
Gene; 2018 Jun; 659():123-127. PubMed ID: 29559350
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D receptor gene polymorphisms are associated with the risk of fractures in postmenopausal women, independently of bone mineral density.
Garnero P; Munoz F; Borel O; Sornay-Rendu E; Delmas PD
J Clin Endocrinol Metab; 2005 Aug; 90(8):4829-35. PubMed ID: 15886235
[TBL] [Abstract][Full Text] [Related]
34. The role of vitamin D receptor gene polymorphisms in the bone mineral density of Greek postmenopausal women with low calcium intake.
Stathopoulou MG; Dedoussis GV; Trovas G; Theodoraki EV; Katsalira A; Dontas IA; Hammond N; Deloukas P; Lyritis GP
J Nutr Biochem; 2011 Aug; 22(8):752-7. PubMed ID: 21115334
[TBL] [Abstract][Full Text] [Related]
35. [Polymorphism of the gene for vitamin D receptor, bone mass, and bone turnover in women with postmenopausal osteoporosis].
Fontova Garrofé R; Gutiérrez Fornés C; Broch Montané M; Aguilar Crespillo C; Pujol del Pozo A; Vendrell Ortega J; Richart Jurado C
Rev Clin Esp; 2000 Apr; 200(4):198-202. PubMed ID: 10857403
[TBL] [Abstract][Full Text] [Related]
36. Correlation between vitamin D receptor genotypes and bone mineral density in Japanese patients with osteoporosis.
Tamai M; Yokouchi M; Komiya S; Mochizuki K; Hidaka S; Narita S; Inoue A; Itoh K
Calcif Tissue Int; 1997 Mar; 60(3):229-32. PubMed ID: 9069156
[TBL] [Abstract][Full Text] [Related]
37. A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis. The Alendronate Research Group.
Shiraki M; Kushida K; Fukunaga M; Kishimoto H; Kaneda K; Minaguchi H; Inoue T; Tomita A; Nagata Y; Nakashima M; Orimo H
Endocr J; 1998 Apr; 45(2):191-201. PubMed ID: 9700472
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D receptor alleles and rates of bone loss: influences of years since menopause and calcium intake.
Krall EA; Parry P; Lichter JB; Dawson-Hughes B
J Bone Miner Res; 1995 Jun; 10(6):978-84. PubMed ID: 7572323
[TBL] [Abstract][Full Text] [Related]
39. Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms?
Ferrari SL; Rizzoli R; Slosman DO; Bonjour JP
J Bone Miner Res; 1998 Mar; 13(3):363-70. PubMed ID: 9525336
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease.
Palomba S; Orio F; Manguso F; Falbo A; Russo T; Tolino A; Tauchmanovà L; Colao A; Doldo P; Mastrantonio P; Zullo F
Osteoporos Int; 2005 Sep; 16(9):1141-9. PubMed ID: 15928801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
